¥28.70
¥-0.60 (-2.05%)
End-of-day quote: 05/17/2024
SHSE:600161

Beijing Tiantan Biological Products Annual Report

Year Year 2023 2022 2021 2020 2019 2018 2017 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005
Rev. Revenue
¥5.18B ¥4.26B ¥4.11B ¥3.45B ¥3.28B ¥2.93B ¥2.48B ¥1.62B ¥1.83B ¥1.84B ¥1.50B ¥1.39B ¥1.20B ¥1.10B ¥967.75M ¥530.50M ¥416.76M ¥343.36M
GM % Gross Margin %
50.72% 49.02% 47.40% 49.47% 49.50% 46.71% 51.13% 43.44% 54.81% 54.26% 55.62% 59.19% 57.60% 63.33% 62.92% 61.77% 55.04% 55.72%
OM Operating Margin
32.93% 30.34% 28.55% 30.44% 31.13% 29.03% 31.10% 18.13% 21.82% 31.59% 29.76% 26.85% 22.81% 34.08% 34.20% 35.65% 30.31% 26.94%
EPS Earnings Per Share
¥0.00 ¥0.67 ¥0.52 ¥0.48 ¥0.42 ¥0.40 ¥0.34 ¥0.28 ¥-0.01 ¥0.08 ¥0.24 ¥0.18 ¥0.15 ¥0.11 ¥0.10 ¥0.09 ¥0.08 ¥0.07 ¥0.05
Div. Dividends
¥0.15 ¥0.05 ¥0.08 ¥0.08 ¥0.04 ¥0.03 ¥0.09 ¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.03 ¥0.03 ¥0.00 ¥0.00 ¥0.05 ¥0.08 ¥0.00
PR % Payout Ratio %
22.39% 9.62% 16.67% 19.05% 10.00% 8.82% 32.14% -0.00% 0.00% 0.00% 0.00% 20.00% 27.27% 0.00% 0 62.50% 114.29% 0
Sha. Shares
1647.81m 1647.81m 1647.81m 1254.44m 1254.44m 1254.44m 1254.44m 1254.44m 1254.44m 1254.44m 1254.44m 1254.44m 1254.44m 1188.21m 1188.21m 1188.21m 1188.21m 1188.21m
OCF Operating Cash Flow
¥2.39B ¥1.13B ¥980.35M ¥702.11M ¥642.47M ¥677.92M ¥138.47M ¥473.26M ¥477.95M ¥566.43M ¥432.00M ¥353.15M ¥184.85M ¥448.23M ¥367.08M ¥153.55M ¥154.36M ¥131.69M
FCF Free Cash Flow
¥1.32B ¥-228.02M ¥-142.84M ¥93.81M ¥133.11M ¥384.30M ¥78.74M ¥172.69M ¥13.79M ¥18.06M ¥-125.87M ¥-365.16M ¥-112.69M ¥257.06M ¥187.70M ¥87.15M ¥82.86M ¥91.91M
FCFS Free Cash Flow Per Share
¥0.79 ¥-0.14 ¥-0.09 ¥0.07 ¥0.09 ¥0.31 ¥-0.06 ¥0.14 ¥0.01 ¥0.01 ¥-0.10 ¥-0.29 ¥-0.09 ¥0.21 ¥0.15 ¥0.07 ¥0.07 ¥0.08